Nigeria
Industry
BMI View: We believe claims about a 50% increase in basic pharmaceutical prices in Nigeria are overblown and sensationalised to further politicise the explosive issue of fuel price...
2012-01-16Industry
BMI View: Adcock Ingram's strategy to expand in Sub-Saharan Africa is going to be a big generator of wealth for the company's future, but it has been slow to expand in the region compared...
2011-10-21Industry
BMI View: China's soft power in the African healthcare sector will become increasingly commercialised as its investment in Africa continues to promote sustainability over aid dependence....
2011-10-14Industry
BMI View: Uncompetitive local drugmakers in Nigeria can only survive with government intervention or investment. This help has come in the form of the Nigerian Pharmaceutical Development...
2011-08-09Industry
BMI View: Healthcare professionals work as a team and, in order to achieve the best clinical results, should be represented by all strata of that team in the management structure. If...
2011-07-26Industry
BMI View: Uncompetitive local drugmakers in Nigeria can only survive with government intervention or investment. This help has come in the form of the Nigerian Pharmaceutical Development...
2011-04-20Industry
BMI View: Uncompetitive local drugmakers in Zimbabwe and Nigeria can only survive with government intervention or foreign direct investment (FDI). This help needs to come in the form...
2011-02-28Industry
BMI View: Specific health needs in emerging markets, which had previously been neglected because of the need to maintain shareholder value, may become commercially viable as average...
2011-01-12
